Immunosuppression and the development of malignancies of the upper airway and related structures

The Laryngoscope
J P Harris, I Penn

Abstract

In the general population, 90% of the malignancies developing in the upper respiratory tract are squamous cell carcinomas. Analysis of 1081 neoplasms in 1023 renal transplant patients reported to the Denver Transplant Tumor Registry indicates that squamous cell carcinoma remains the predominant malignancy which develops in the upper respiratory tract of immunosuppressed individuals. Comparing the incidence of cancers of the oral cavity (excluding lip cancers) in the immunosuppressed population with the general population it is rather similar (3.5% vs. 4%). When lip cancers are included, one sees a great excess of tumors developing in transplant patients (15% vs. 4.6%). Thus the excess of head an neck epithelial malignancies among these patients is confined to neoplasms of the lip. Examination of the 25 patients reported in this study reveals an unusually young age of the patients, the average age being 41.8 years compared with the general population where most head an neck tumors occur in the 55-65 age group. The average time post-transplantation when cancer developed was 5.3 years, supporting the concept that the more effective the immunosuppressive regimen for prevention of graft rejection, the greater the susceptibility for ...Continue Reading

Citations

Apr 5, 2002·Head & Neck·Diego A PreciadoGeorge L Adams
Dec 13, 2000·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·S Meng, L Jiamei
Mar 23, 2010·Journal of the American Academy of Dermatology·Barbara C BöckleNorbert T Sepp
Nov 29, 2005·International Journal of Experimental Pathology·Giovana R ThomasJacinto Regalado
May 4, 2007·Periodontology 2000·Asvin Vasanthan, Nadeem Dallal
Jan 22, 2005·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Nour J MusaLida Radfar
Oct 14, 2003·Pathology·D Murray WalkerLouise A McDonald
Mar 31, 1998·Journal of the American Academy of Dermatology·E J van ZuurenJ N Bouwes Bavinck
Apr 1, 1992·Oral Surgery, Oral Medicine, and Oral Pathology·E RegevJ Lustmann
Jun 20, 2006·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Federico L AmpilDavid D Kim
Jul 14, 1998·International Journal of Oral and Maxillofacial Surgery·J G de Visscher, I van der Waal
Apr 1, 1997·International Journal of Oral and Maxillofacial Surgery·J G de VisscherI van der Waal
May 29, 2004·Current Opinion in Otolaryngology & Head and Neck Surgery·Christine G Gourin, David J Terris
Aug 1, 1997·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·R A SeymourA Nolan
Mar 21, 2002·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·L ZhangM P Rosin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

© 2021 Meta ULC. All rights reserved